Gaush Meditech

Gaush Meditech EBITDA per Employee

The EBITDA per Employee of Gaush Meditech (2407.HK) as of Nov 2, 2026 is 148,170.52 CNY. In the previous year, EBITDA per Employee was 205,447.65 CNY — a change of -27.88% (lower).

EBITDA per Employee

148,170.52CNY

YoY

-27.88%

Last updated:

EBITDA per Employee of Gaush Meditech is 2025 148,170.52 CNY. EBITDA per Employee of Gaush Meditech was 2024 205,447.65 CNY. It decreases by -27.88% lower compared to the previous year.

The Gaush Meditech EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2019
185,176.48 CNY
Jan 1, 2020
189,759.79 CNY
Jan 1, 2021
267,887.54 CNY
Jan 1, 2022
256,539.20 CNY
Jan 1, 2023
290,850.97 CNY
Jan 1, 2024
205,447.65 CNY
Jan 1, 2025
148,170.52 CNY
The Gaush Meditech EBITDA per Employee history
YEAREBITDA per EmployeeYoY
148,170.52CNY-27.88%
205,447.65CNY-29.36%
290,850.97CNY+13.37%
256,539.20CNY-4.24%
267,887.54CNY+41.17%
189,759.79CNY+2.48%
185,176.48CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Gaush Meditech Stock analysis

What does Gaush Meditech do? Gaush Meditech Ltd. generates revenue through four business segments. The Proprietary Products segment develops and sells surgical equipment, intraocular lenses, and diagnostic and treatment devices for ophthalmic diseases, along with related software and consumables. The Distribution segment distributes branded ophthalmic medical devices and consumables. The Technical Services segment offers after-sales services including warranty, maintenance, and consumables support. The Others segment handles equipment leasing and intellectual property agency services. Products are used in treating conditions like cataracts, glaucoma, and pediatric ophthalmology across various medical specialties. The company's primary customers include hospitals, clinics, and medical institutions specializing in ophthalmology. These institutions purchase proprietary devices, branded consumables, and technical support services. The firm's focus on ophthalmic subspecialties ensures consistent demand for its products and services in the treatment of eye diseases. Revenue streams are diversified across product development, distribution, and post-sale services. The proprietary segment drives innovation with surgical equipment and lenses, while distribution and technical services provide steady income from established medical partners. Equipment leasing and IP services in the Others segment contribute to additional revenue without requiring direct product sales. Gaush Meditech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gaush Meditech stock

EBITDA per Employee of Gaush Meditech is 148,170.52 CNY in 2025.

EBITDA per Employee of Gaush Meditech changed from 205,447.65 CNY to 148,170.52 CNY, representing a -27.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Gaush Meditech since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Gaush Meditech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Gaush Meditech

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Gaush Meditech